🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honored to introduce our new Mentorship & Sponsorship Committee, dedicated to supporting Hematology-Oncology fellowship applicants. Excited to help guide and uplift future leaders in our field. Grateful to #IMGoncCoP for entrusting me with this important initiative. Toni Choueiri, MD

So great to be among the most inspiring women in oncology! 💫 Loved catching up with Narjust Florez, MD, FASCO , Nina Shah , and Rachna Shroff, MD, MS, FASCO — brilliant minds, kind hearts, and true leaders.✨ #ASCO25

😇I'm thrilled and humbled to receive the Next Gen Disruptor Award. Heartfelt thanks HemOnc Today Healio! ASCO #ASCO25 #HealioInnovators 🙏I'm deeply grateful for the incredible mentors, sponsors, collaborators and friends who opened doors and supported me along the way.

Great to see colleagues and friends at the MD Anderson Cancer Center booth at #ASCO25. #EndCancer Nitin Jain Michael Wang, MD Naveen Pemmaraju, MD Shannon Westin, MD, MPH, FASCO

Very proud of Dr Vishwanath Sathyanarayanan, founder of the CPOEM FOUNDATION group that is a leading light sharing medical education with physicians in India and around the world. #ASCO25 #Mentorship

Such an honor to receive the Conquer Cancer – Nizar M. Tannir, MD, Endowed Merit Award and to share this moment with Dr. Tannir himself at #ASCO25. Grateful for the support of early-career researchers and thankful to my mentor Sumanta K. Pal, MD, FASCO and senior author @NazliDizmanMD.

Thanks to Eric J. Small, MD, FASCO for coming to our session on Advocacy, Speaking To Power With Power at #ASCO25. Check out the session: meetings.asco.org/2025-asco-annu…

Thanks #ASCO25- you were surely extra special 💕🎀🥰🥳 ✅endowed and handed over the Kamboj Christie YIA award ✅attended CoP - AI, Palliative Oncology, IMG ✅hosted CoP - Policy; ✅presented Advocacy 101 ✅got FASCO W Family/ Friends ✅got Yvonne award for Comminity Oncology

Oncologists are “losing the battle” against misinformation. The Times and The Sunday Times on #ASCO25 research presented ASCO including our work showing survivors worry about finding high quality cancer info online & that trust in science is at risk. 🙏✍️Poppy Koronka thetimes.com/uk/healthcare/…

“The addition of maintenance olaparib really shines in the DNA mismatch repair proficient population,” said our Dr. Shannon Westin, MD, MPH, FASCO of exploratory analyses of longitudinal ctDNA from the DUO-E trial at #ASCO25. ASCO #EndCancer

Really interesting data to help predict pneumonitis in patients treated with ADCs- will need to explore this further in Gyn Ca #ASCO25 #gyncsm

What if you could predict and prevent relapse in #DLBCL? Don’t miss this Satellite Symposium at #ICML2025, where experts will discuss potentially advancing beyond "watch and wait" with investigational MRD testing and allogeneic #CART. #Immunotherapy $ALLO Register Here:

My husband, the incredible Lymphoma specialist Jason Westin, MD FACP FASCO - has been a tireless advocate for our patients and ASCO - check out his master class on how to advocate as a physician....Definitely required viewing!!! #ASCO25 #advocacy shorturl.at/zMxCy

My last meeting at #ASCO25 was International Affairs Committee meeting which was scheduled right after the ASCO Business meeting. Dr Eric Small arrived few minutes late(since he was at the business meeting) and said, Sorry I am late, I was busy becoming the ASCO President.

🚨 Reminder: The deadline to submit your abstract for #ASCOQLTY25 is June 10! ASCO Don’t miss the chance to share your work and help shape the future of cancer care delivery Submit here: asco.confex.com/asco/qcs2025/c…

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial [Dec 29, 2012] Jason Westin, MD FACP FASCO Mike Thompson, MD, PhD, FASCO et al. CLML ow.ly/zENQp #lymsm #SuppOnc #BoneHealth #NCT00352846

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial [Dec 29, 2012] Jason Westin, MD FACP FASCO Mike Thompson, MD, PhD, FASCO et al. CLML ow.ly/zENQp #lymsm #SuppOnc #BoneHealth #NCT00352846

What is your why? This is mine 🥹

Thrilled to see David Russler-Germain, MD/PhD present our work as a plenary at #18ICML, with excellent discussion from Steve Ansell. The paper will be online tonight, with a summary to follow.

This work will be hugely important to help define a path forward for treating DLBCL: which patients are most likely to benefit from CAR T-cell, work to be done to understand if other therapies could overcome adverse biology. We are open to collaborate!